Contraception Choice among HIV-Positive Women Utilizing Family Planning Services Integrated with HIV Care at the Antiretroviral Therapy Clinic of Jos University Teaching Hospital, Nigeria

##plugins.themes.bootstrap3.article.main##

  •   Halima Sule

  •   Mark Gyang

  •   Tinuade Oyebode

  •   Margaret Tersoo

Abstract

Transmission of Human Immunodeficiency Virus from a pregnant HIV-infected woman to her unborn child is one of the ways through which new HIV infections can be acquired. Utilization of contraceptives among HIV-positive women can prevent unintended pregnancies, and the use of dual methods reduces the risk of transmission of sexually transmitted infections including HIV, hence the need to support contraception in them. This study sought to describe the various choices of contraception used by women accessing family planning services integrated with the antiretroviral therapy facility of Jos University Teaching Hospital. In a retrospective study, relevant information was extracted from the records of all women who had sought contraception in the Family Planning unit of the facility from 1st March 2019 – 29th February 2020. The data obtained was analysed using EPI info 7 statistical software. Results: A total of 137 records were reviewed. The most frequent choice of contraception was hormonal implants (61.3%), while the least frequent choice was using condoms alone (1.5%). Less than half (46.7%) of them used dual contraception. Secondary and tertiary educational status, as well as disclosure of HIV-positive status to partner were significantly associated with utilization of dual contraceptive methods (P value =0.0010 and 0.0245 respectively; Odds ratio =5.8199 and 4.3307 respectively). Conclusion: Integration of family planning services with HIV care as a strategy for the prevention of unintended pregnancy is promoted in this facility but there is need to improve the uptake particularly of dual method of contraception. There is also need for inclusion of IUCD in the choices of contraception offered as this method is highly effective, long lasting and has been proven to be safe in well selected HIV patients. Furthermore, screening the clients to identify unmet needs and implementing strategies to meet those needs would enhance the impact of family planning.


Keywords: Contraception, Dual method, Family planning, HIV-positive women, Nigeria.

References

WHO. Global Health Observatory data. (2018). Available at: https://www.who.int/gho/hiv/en/ [Accessed on October 12, 2019].

UNAIDS. (2019). The global HIV& AIDS statistics. Available: https://www.unaids.org/en/resources/fact-sheet.

UNAIDS. (2018). Start free. Stay free. AIDS free:2017 progress report. Available https://www.unaids.org/en/resources/documents/2018/start-free--stay-free-aids-free-2017-progress-report.

Avert.org. (2018). HIV and AIDs in Nigeria. Available: https://www.avert.org/professionals/hiv-around-world/sub-saharan-africa/Nigeria.

NACA. (2017). National Strategic Framework on HIV and AIDS: 2017-2021. Available at https://www.childrenandaids.org/sites/default/files/2017-11/NATIONAL-HIV-AND-AIDS-STRATEGIC-FRAMEWORK.pdf.

UNAIDS. (2016). prevention gap report. Available: https://www.unaids.org/sites/default/files/media_asset/2016prevention-gap-report_en.pdf.

B. Zaba, C. Calvert, M. Marston, R. Isingo, J. Nakiyingi-Miiro, T. Lutalo, et al. “Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa:secondary analyses of pooled community-based data from the network for analysing longitudinal population-based HIV/AIDS data on Africa (ALPHA)”, Lancet. vol 381, no 9879, pp 1763-1771. 2013.

S. Darak, I. Hutter, V. Kulkarni, S. Kulkarni and F. Janssen. “High prevalence of unwanted pregnancies and induced abortions among HIV-infected women from West India: Need to emphasize dual method use?”, AIDS Care. vol. 28, no 1, pp 43-51, Aug 2016.

O. V. Adeniyi, A. I. Ajayi, M. G. Moyaki , D. T. Goon, G. Avramovic and J. Lambert. “High rate of unplanned pregnancy in the context of integrated family planning and HIV care services in South Africa”, BMC Health Serv Res.vol. 18, no 140, 8pgs, Feb. 2018.

V. Iyun, K. Brittain, T. K. Phillips, S. le Roux, J. A. McIntyre, A. Zerbe et al. “Prevalence and determinants of unplanned pregnancy in HIV-positive and HIV-negative pregnant women in Cape Town, South Africa: a cross-sectional study”, BMJ Open. vol. 8, no 4, e019979, Apr. 2018.

A. G. Mersha, D. A. Erku, S. A. Belachew, A. A. Ayele, B. M. Gebresillassie et al. “Contraceptive use among HIV-positive and negative women: implication to end unintended pregnancy.” Contracept Reprod Med. vol. 4, no 3, Feb. 2019.

WHO. (2020) HIV/AIDS.Mother to child transmission of HIV. Available: https://www.who.int/hiv/topics/mtct/en.

C. Calvert and C. Ronsmans. “HIV and the risk of direct obstetric complication: asystematic review and meta-analysis.” PLoS ONE, vol. 8, no 10, e74848, Oct. 2013.

H. W. Reynolds, B. Janowitz, R. Homan, L. Johnson. “The value of contraception to prevent perinatal HIV transmission.” Sex Transm Dis, vol.33, no 6, pp. 350-356, Jun 2006.

WHO. (Dec 2015). “Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals.” Available: https://www.who.int/gho/publications/mdgs-sdgs/en/ [Accessed on February 22, 2020], Dec 2015.

E. E. Chinaeke, C. Fan-Osuala, M. Bathnna, C. E. Ozigbu, B. Olakunde, H. O. Ramadhani et al. “Correlates of reported modern contraceptive use among postpartum HIV-positive women in rural Nigeria: an analysis from the MoMent prospective cohort study.” Reprod Health,vol 16, no 2, Jan. 2019.

C. C. Okigbo, D. R. McCarraher, M. Chen, U. Gwarzo, G. Vance, and O. Chabikuli. “Unmet need for contraception among clients of FP/HIV Integrated services in Nigeria: The role of partner opposition.” Afr J Reprod Health, vol.18, no 2, pp. 134-143, Jun. 2014.

I. Yaya, A. A. Patassi, D. E. Landoh, E. M. Bignandi, K. Kolani, A. D. Namoro AD et al. “Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study.” BMJ Open, vol.8, no 4, e019006, Apr. 2018.

F. A. Abubeker, M. B. Fanta, and V. K. Dalton. “Unmet need for contraception among HIV-positive women attending HIV care and treatmentservice at Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia.” Int J Rep Med, ID3276780, 7pgs, Aug. 2019.

J. D. Damian, J. M. George, E. Martin, B. Temba, and S. E. Msuya. “Prevalence and factors influencing modern contraception use among HIV-positive women in Kilmanjaro region, northern Tanzania.” Contracept and Reprod Med, vol.3 no 7, 9 pgs. May 2018.

F. Bongomin, M. Chelangat, A. Eriatu, B. C. Onen, P. Cheputyo, S. A. Godmercy et al. “Prevalence and factors associated with contraception use among HIV-infected women of reproductive age attending infectious disease clinic at Gulu Regional Referral Hospital, Northern Uganda.” Biomed Res Int.2018:9680514, Jun. 2018.

N. L. Hancock, C.J. Chibwesha, S. Bosomprah, J. Newman, M. Mubiana-Mbewe, E. S. Sitali et al. “Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional survey.” BMC Pub Healt. Vol.16, no 392, 8pgs, May 2016.

A. A. Creanga, D. Gillespie, S. Karklins and A. O. Tsui. “Low use of contraception among poor women in Africa: an equity issue.” Bull World Health Organ, vol. 89 no 4, pp 258-266. Feb. 2011.

R. Wilcher and W. Cates. “Reproductive choices for women with HIV.” Bull World Health Organ, vol.87, no 11, pp 833-839, Nov. 2009.

C. E. Enyinda and B. O. Enaohwo. “Contraception prevalence and pattern among HIV positive women in Port Harcourt, south-south Nigeria.” J Reproduc Contracep, vol. 23 no 3, pp186 – 192. Sept. 2012.

A. M. Mulongo, R. W. Lihana, J. Githuku, Z. Gura and S. Karanja. “Factors associated with uptake of dual contraception among HIV-infected women in Bungoma County, Kenya: a cross sectional study.” PAMJ, vol. 28 no 1, S 2. Nov. 2017.

F. Abay, H. Y. Yeshita, F. A. Mekonnen and M. Sisay. “Dual contraception method utilization and associated factors among sexually active women on antiretroviral therapy in Gondar City, northwest Ethiopia: a cross sectional study.” BMC Women’s Health, vol 20 no 26, 9 pgs. Feb. 2020.

B. Joshi, G. Velhal, S. Chauhan, R. Kulkarni, S. Begum and Linkage Study Team. “Linking HIV and family planning services to improve dual methods of contraception among women infected with HIV in Mumbai, Maharashtra, India.” Indian J Med Res, vol 143 no 4, pp 464 – 473. Apr. 2016.

A. U. Shehu, I. A. Joshua and Z. Umar. “Knowledge of contraception and contraceptive choices among Human Immunodefficiency Virus-positive women attending antiretroviral clinics in Zaria, Nigeria.” Sub-Sahr Afr J Med, vol. 3, no 2, pp84-90, Jun. 2016.

H. S. Mitchell and E Stephens. “Contraception choice for HIV-positive women.” Sex Transm Infect, vol. 80 no 3, pp 167-173. Jun. 2004.

C. J. Chibwesha, M. S. Li, C. K. Matoba, R.K. Mbewe, B. H. Chi, Stringer JSA, et al. “Modern contraceptive and dual method use among HIV-infected women in Lusaka, Zambia.” Infect dis Obs Gynecol, vol 2011, ID261453, 8 pgs, Oct. 2011.

K. A. Alene and K. A. Atelell. “Contraceptive use and method preference among HIV-positive women in Amhara region, Ethiopia.” BMC Women’s Health, vol 18, no 97. Jun. 2018.

A. E. Ogbe and J. T. Mutihir. “Pattern of contraception among HIV-positive women in Jos University Teaching Hospital.” Niger J Med, vol. 21, no 1 pp 11-15, Jan. 2012.

J. D. Ojule, E. O. Oranu and B. C. Unamba. “Contraceptive practice among HIV positive women attending antiretroviral clinic at the University of Port Harcourt Teaching Hospital, Port Harcourt, southern Nigeria.” East Afr Med J, vol. 92, no 1, pp 9-14, Jan. 2015.

L. O. Lawani, A. K. Onyebuchi and C. A. Iyoke. “Dual method use for protection of pregnancy and disease prevention among HIV-infected women in southeast Nigeria.” BMC Women’s Health, vol. 14, no 39, 6 pgs, Mar. 2014.

C. I. Nieves, A. Kaida, G. R. Seage, J. Kabakyenga, W. Muyindike, Y. Boum et al. “The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda.” Contracept, vol. 92, no 2, pp 152-159. Aug. 2015.

WHO. Medical eligibility criteria for contraceptive use 5th edition. (2015). Available: https://www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/.

O. Heikinheimo, P. Lehtovirta, I. Aho, M. Ristola and J. Paavonen. “The levonorgestrel-realising intrauterine system in Human Immunodeficiency Virus-infected women: a 5-year follow-up study.” Am J Obstet Gynecol, vol 204, no 2 pp 126.e1-4, Feb. 2011.

C. S. Todd, H. E. Jones, T. C. Garber, H. Afnan-Holes, H. Woolgar, L. Bekker et al. “Awareness and interest in intrauterine contraceptive device use among HIV-positive women in Cape Town, South Africa.” Infect Dis Obstet Gynecol, vol 2012, ID956145, 8 pgs, Jun. 2012.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Sule, H., Gyang, M., Oyebode, T., & Tersoo, M. (2020). Contraception Choice among HIV-Positive Women Utilizing Family Planning Services Integrated with HIV Care at the Antiretroviral Therapy Clinic of Jos University Teaching Hospital, Nigeria. European Journal of Medical and Health Sciences, 2(5). https://doi.org/10.24018/ejmed.2020.2.5.475